[Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia]
- PMID: 18780573
[Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia]
Abstract
Two main causes of early mortality of acute promyelocytic leukemia (APL) are rewieved, unique type ofcoagulopathy typical for APL and differentiation syndrome sometimes complicating treatment of APL with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO). The information covers analysis of the patophysiologies of both conditions and also recommendations considering treatments and preventive measures.
Similar articles
-
Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?Leuk Lymphoma. 2017 Jul;58(7):1743-1746. doi: 10.1080/10428194.2016.1253838. Epub 2016 Dec 6. Leuk Lymphoma. 2017. PMID: 27919176 No abstract available.
-
Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia.Hematology. 2014 Jun;19(4):202-7. doi: 10.1179/1607845413Y.0000000118. Epub 2013 Nov 25. Hematology. 2014. PMID: 24074286
-
Acute promyelocytic leukemia: a paradigm for differentiation therapy.Cancer Treat Res. 2010;145:219-35. doi: 10.1007/978-0-387-69259-3_13. Cancer Treat Res. 2010. PMID: 20306254 Review.
-
Differentiation syndrome in patients with acute promyelocytic leukemia.J Oncol Pharm Pract. 2012 Mar;18(1):109-14. doi: 10.1177/1078155211399163. Epub 2011 Mar 1. J Oncol Pharm Pract. 2012. PMID: 21364078 Review.
-
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.J Clin Oncol. 2000 Jul;18(13):2620-5. doi: 10.1200/JCO.2000.18.13.2620. J Clin Oncol. 2000. PMID: 10893295
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical